About this Episode
In this special episode, co-hosts Sara Le Brun-Blashka, MS, and Weston Bussler, PhD, talk with Dr. Lars Bode about human milk oligosaccharides (HMOs), namely 2’-fucosyllactose (2’-FL).
Dr. Bode discusses the relationship between 2’-FL, a novel prebiotic, and the human microbiome, including what makes 2’-FL stand out from other HMOs, and why HMOs stand out from other oligosaccharides. Additionally, the group talks about the decoy action of HMOs and the relationship between 2’-FL and Bifidobacteria.
About Our Guest
Dr. Lars Bode has been working on human milk oligosaccharides (HMOs) for over 20 years. He received both his Master of Science and PhD degree in Nutritional Sciences from the Justus-Liebig University Giessen, Germany. Dr. Bode joined the University of California, San Diego, where he is leading a research program dedicated to investigating HMO biosynthesis and functions with potential benefits for infant health and development.
Dr. Bode has published over 100 peer-reviewed articles on human milk oligosaccharides, including the 2012 review “Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama,” which has become the most cited research article in the field of human milk oligosaccharides.
Dr. Bode is Professor of Pediatrics in the Division of Neonatology and the Division of Gastroenterology, Hepatology and Nutrition, the Larsson-Rosenquist Chair of Collaborative Human Milk Research, and Director of the Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence at the University of California, San Diego.
